IVONESCIMAB
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy
China’s biotech is redrawing the global pharma map; what India can learn
You thought only DeepSeek routed American titans? Wait, here's a little-known Chinese biotech company whose lung cancer drug could rattle big pharma; here's all about it
- Load More